Open Access

Poster Session 3 - Cardiac patients with comorbidities

Event: ESC Congress 2018
Topic: European Society of Cardiology, Other
Session type: Poster Session
Date: 26 August 2018

Session

6 presentations in this session

Increase in pulse rate with semaglutide did not result in increased adverse cardiac events in subjects with type 2 diabetes in the SUSTAIN 6 cardiovascular outcomes trial

Speaker: Professor J. Seufert (Freiburg, DE)
Thumbnail

Liraglutide reduces cardiovascular events and mortality in type 2 diabetes independent of LDL cholesterol and statin use: results of the LEADER trial

Speaker: Professor S. Verma (Toronto, CA)
Thumbnail

Semaglutide consistently reduces cardiovascular risk in patients with type 2 diabetes regardless of baseline cardiovascular risk level: post hoc analyses of the SUSTAIN trial programme

Speaker: Professor S. Bain (Swansea, GB)
Thumbnail

MRI evaluation of the impact of metformin and dapagloflizin on epicardial adipose tissue area in prediabetes and type 2 diabetes patients

Speaker: Professor C. Lang (Dundee, GB)
Thumbnail

A systematic review and meta-analysis of anti-cytokine therapies targeting IL-1 and TNF- A in myocardial infarction and heart failure

Speaker: Ms M. Panahi (London, GB)
Thumbnail

Additional therapy with nicorandil and quality of life in patients with stable coronary heart disease: a multicenter observational study

Speaker: Professor S. Martsevich (Moscow, RU)
Thumbnail

6 speakers from this session

Professor Jochen Seufert

University of Freiburg, Freiburg (Germany)
0 follower

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
16 presentations
0 follower

Professor Steve Bain

Swansea University, Swansea (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Professor Chim Choy Lang

University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)
0 follower

Ms Mona Panahi

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Professor Sergey Martsevich

National Medical Research Center for Preventive Medicine, Moscow (Russian Federation)
0 follower

This platform is supported by

logo Novo Nordisk